Bayer, Mitsui Chemicals Agro to develop novel parasiticides for petsJuly 9, 2018Bayer Animal Health GmbH and Mitsui Chemicals Agro Inc. (MCAG) have signed a global license agreement in which Bayer will develop novel companion animal parasiticide compounds based on MCAG's intellectual property. Further terms of the agreement were not disclosed. "At Bayer, we passionately care for the health and well-being of animals," said Dr. Dirk Ehle, head of Bayer Animal Health. "And we have long been committed to help pet owners protect their animals from parasites. Today we have taken an important next step to further deliver on this commitment to our customers." "This license agreement combines the strong science base within Bayer with innovative chemistry from MCAG," said Dr. Sabine Bongaerts, head of Bayer drug discovery. "It will enable us to further expand our strong portfolio of parasiticides in the companion animal sector and deliver new compelling products to our customers." "Under the concept of technology and innovation, MCAG has been providing its innovative products and services to the customers in agrochemicals and environmental health businesses for many years so far," said Satoshi Ozawa, president and CEO of MCAG. "Now, through close and successful collaboration with Bayer in the animal health sector, we …
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
